External beam radiotherapy is associated with a 10% survival advantage in women with deeply myoinvasive, high-grade endometrial cancer only, but women at lower risk of recurrence do not benefit.

As the rates of obesity and severe obesity continue to increase, this technology will become increasingly vital to providing the highest quality care for the endometrial cancer population.

At the ASCO 2024, four clinically very important abstracts in endometrial cancer were presented. Long-term survival for ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

Lenvima plus Keytruda did not significantly improve survival or progression-free survival compared to chemotherapy in advanced endometrial cancer. The study involved ... and 37.7 months versus 32.1 ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

A CT scan showed signs of advanced endometrial malignancy with "disseminated metastasis". This prompted a report on January biopsy, said the report, which showed "grade one" womb cancer.